Prosthetics, Orthotics and Cosmetic Enhancement Products
Published By: BCC Research
October 2005
R2-1113
Online Download $4,543.00
Hard Copy Mail Delivery $4,543.00 (Subject to Shipping Charges)
Global Site License $7,900.00
Description
INTRODUCTION
The prosthetics, orthotics and cosmetic enhancement products industries are entering into a period of extraordinary opportunities. This is due to a convergence of technological, demographic, cultural and economic factors. Advances in materials technology, miniaturization, electronics and operative procedures are opening up many new possibilities.
At the same time, the populations of the U.S. and other advanced countries are growing older, resulting in a continual growth in the number of people suffering from physical disabilities and other conditions that medical science increasingly is equipped to ameliorate. Many of these same individuals have enjoyed unprecedented earnings during their working lives, and look forward to financially comfortable retirement years. As a result, they will have the money to spend on prosthetics, orthotics and cosmetic enhancement products, with or without the help of health insurance.
This BCC report is both a survey of products on the marketplace and a preview of things to come. The study examines market opportunities for prosthetic and orthotics devices and cosmetic enhancement products and the technologies that make possible the more advanced products that rapidly are coming into being.
SCOPE OF STUDY
The report contains:
Discussion of major product types and applications, both commercial and developmental
An overview of market size and segmentation, including historical data on sales by application and product type
Market drivers and constraints
Detailed market projections through 2010
Analysis of industry structure, competition and market shares
Discussion of factors that may influence the long-term market for prosthetic and orthotics devices and cosmetic enhancement products.
METHODOLOGY AND INFORMATION SOURCES
The findings and conclusions of this report are based on information gathered from manufacturers and distributors, hospitals, doctors, and other end users. Interview data were combined with information gathered through an extensive review of secondary sources such as trade publications, trade associations, company literature, and on-line databases to produce the baseline market estimates contained in this report.
The base year for analysis and projection is 2004. With 2004 as a baseline, market projections were developed for 2005 to 2010. These projections are based on consensus among the primary contacts in combination with our understanding of the key market drivers and their impact from a historical and analytical perspective. The analytical methodologies used to generate the market estimates are described in detail in the section on Detailed Market Projections.
All dollar projections presented in this report are in 2004 constant dollars
|
Table of Contents
INTRODUCTION
STUDY BACKGROUND
STUDY GOALS AND OBJECTIVES
INTENDED AUDIENCE
SCOPE AND FORMAT
METHODOLOGY AND INFORMATION SOURCES
ANALYST CREDENTIALS
RELATED BCC, INC. RESEARCH
BCC ONLINE SERVICES
DISCLAIMER
EXECUTIVE SUMMARY
Summary Table:
U.S. MARKET FOR PROSTHETICS, ORTHOTICS AND COSMETIC ENHANCEMENT PRODUCTS, THROUGH 2010 ($ MILLIONS)
Summary Figure:
U.S. MARKET FOR PROSTHETICS, ORTHOTICS AND COSMETIC ENHANCEMENT PRODUCTS, 2004-2010 ($ MILLIONS)
OVERVIEW OF PROSTHETICS, ORTHOTICS, AND BODY ENHANCEMENT PRODUCTS
GENERAL DESCRIPTION
PROSTHETICS
ORTHOTICS
COSMETIC ENHANCEMENT PRODUCTS
HISTORY
PROSTHETIC LIMBS
IMPLANTABLE PROSTHETIC DEVICES
Neurostimulators
Cardiac Prosthetic Devices
Ear Implants
Eye Implants
COSMETIC ENHANCEMENT PRODUCTS
TECHNOLOGIES
MATERIALS
Nanotechnology
Synthetic Bone and Tooth Enamel
Nanostructured Titanium
MINIATURIZATION
ELECTRONICS
Microprocessors
Motors and Controllers
Sensors
Power Sources
OPERATIVE PROCEDURES
Computer-Assisted Hip and Knee Replacement Surgery
Robotic Surgery
APPLICATIONS
AMPUTATIONS
Table 1 MAIN CAUSES OF LIMB LOSS OR DEFICIENCY IN THE U.S.
Table 2 PERSONS IN THE U.S., LIVING WITH LIMB LOSS, BY AGE GROUP (NUMBER, %)
Figure 1 PERSONS IN THE U.S., LIVING WITH LIMB LOSS, BY AGE GROUP (%)
BIRTH DEFECTS
CANCER
Breast Cancer
Table 3 NEW BREAST CANCER CASES DIAGNOSED IN THE U.S, 1999-2004 (THOUSANDS)
Figure 2 NEW BREAST CANCER CASES DIAGNOSED IN THE U.S, 1999-2004 (THOUSANDS)
Bone Cancer
Table 4 ORIGIN, LOCATION AND COMMON AGE FOR TYPES OF BONE CANCER
CARDIOVASCULAR DISEASE
Table 5 HOSPITALIZATIONS, PHYSICIAN OFFICE VISITS AND DEATHS DUE TO HEART DISEASE IN THE U.S., 2001/2002*
SPINAL CORD INJURY
IMPAIRED HEARING
BLINDNESS
UROLOGICAL DISORDERS
Stress Urinary Incontinence
Impotence
PRODUCT TYPES
FUNCTIONAL PROSTHESES
EXOPROSTHESES
Description
Applications
Technologies
Attachment
Power Source
Body-Powered
Electrically Powered
Hybrid
Control
Myoelectric Control
Victhom A-Leg
Otto Bock C-Leg
Activity Specific Prosthesis
Terminal Device
Prosthetic Hands
Prosthetic Feet
Articulation
Replacement Joint
Prosthetic Joints
Patents
Table 6 U.S. EXOPROSTHESIS PATENTS ISSUED SINCE 1976 (NUMBER, %)
Figure 3 U.S., EXOPROSTHESIS PATENTS ISSUED SINCE 1976 (%)
Table 7 U.S. EXOPROSTHESIS PATENT HOLDERS, ISSUED SINCE 1976 (NUMBER, %)
Figure 4 U.S., EXOPROSTHESIS PATENT HOLDERS, ISSUED SINCE 1976 (PERCENT OF PATENTS)
Manufacturers and Market Shares
Table 8 EXOPROSTHESIS MANUFACTURERS, BY LOCATION AND PRODUCTS
Table 9 U.S. EXOPROSTHETIC MARKET SHARES, 2004 ($ MILLIONS, %)
Figure 5 U.S. EXOPROSTHETIC MARKET SHARES, 2004 (PERCENT OF TOTAL MARKET)
ENDOPROSTHESES
Cardiac Prostheses
Description
Applications
Technology
Table 10 CARDIAC PROSTHETIC DEVICES
Electric vs. Pneumatic Powered
Longevity
Miniaturization
Patent Analysis
Table 11 CARDIAC ASSISTANCE/REPLACEMENT DEVICE PATENT HOLDERS, ISSUED SINCE 1976 (NUMBER, %)
Figure 6 CARDIAC ASSISTANCE/REPLACEMENT DEVICE PATENT HOLDERS, ISSUED SINCE 1976 (%)
Manufacturers
Table 12 CARDIAC PROSTHESIS MANUFACTURERS
Table 13 U.S., CARDIAC PROSTHESIS MARKET SHARES, 2004 ($ MILLIONS, %)
Figure 7 U.S., CARDIAC PROSTHESIS MARKET SHARES, 2004 (PERCENT OF TOTAL MARKET)
Ocular Prostheses
Technologies
Cortical Implants
Retinal Implants
Boston Retinal Implant Project
Intraocular Retinal Prosthesis Group
Optobionics Corporation
Research in Germany
Research in Japan
Other Research
Optic Nerve Stimulator
Auditory Prostheses
Cochlear Implants
Applications
Technology
Multi-Channel Cochlear Implants
Single-Electrode Cochlear Implants
Speech Coding
Miniaturization
Patent Analysis
Table 14 COCHLEAR IMPLANT PATENT HOLDERS, SINCE 1976 (NUMBER, %)
Figure 8 COCHLEAR IMPLANT PATENT HOLDERS, SINCE 1976 (%)
Table 15 COCHLEAR IMPLANT PATENTS
Manufacturers
Table 16 COCHLEAR IMPLANT MANUFACTURERS
Table 17 COCHLEAR IMPLANT MARKET SHARES, 2004 ($ MILLIONS, %)
Figure 9 COCHLEAR IMPLANT MARKET SHARES, 2004 (PERCENT OF TOTAL MARKET)
Middle Ear Implants
Description
Applications
Technologies
Piezo-Electric Middle Ear Implants
Electromagnetic Middle Ear Implants
Other Differences
Patent Analysis
Table 18 MIDDLE EAR IMPLANT PATENT HOLDERS, SINCE 1976 (NUMBER, %)
Figure 10 MIDDLE EAR IMPLANT PATENT HOLDERS, SINCE 1976 (%)
Manufacturers
Table 19 MIDDLE EAR IMPLANT MANUFACTURERS
Table 20 MIDDLE EAR IMPLANT MARKET SHARES, 2004 ($ MILLIONS, %)
Figure 11 MIDDLE EAR IMPLANT MARKET SHARES, 2004 (PERCENT OF TOTAL SEGMENT SALES) (PERCENT OF TOTAL SALES)
Neural Prostheses
Description
Applications
Technologies
Freehand
Vocare
Dobelle Implantable Breathing Pacemaker
Other Spinal Nerve Stimulators for SCI
Patents
Manufacturers
Urogenital Prostheses
Urological Prostheses
Urinary Sphincter Prosthesis
Description
Applications
Technologies
Patents
Table 21 URINARY PROSTHETIC SPHINCTER PATENT HOLDERS, ISSUED SINCE 1976 (NUMBER, %)
Figure 12 URINARY PROSTHETIC SPHINCTER PATENT HOLDERS, ISSUED SINCE 1976 (%)
Manufacturers
Table 22 URINARY PROSTHESIS MANUFACTURERS
Penile Prosthesis
Description
Applications
Technologies
Patents
Table 23 U.S. PENILE PROSTHESIS PATENTS ISSUED SINCE 1976, BY TYPE OF PROSTHESIS (NUMBER, %)
Figure 13 U.S. PENILE PROSTHESIS PATENTS ISSUED SINCE 1976, BY TYPE OF PROSTHESIS (PERCENT OF TOTAL PATENTS ISSUED)
Table 24 U.S. PENILE PROSTHESIS PATENT HOLDERS, ISSUED SINCE 1976 (NUMBER, %)
Figure 14 U.S. PENILE PROSTHESIS PATENT HOLDERS, ISSUED SINCE 1976 (%)
Manufacturers
Table 25 PENILE IMPLANT MANUFACTURERS' U.S. MARKET SHARES, 2004 ($ MILLIONS, %)
Figure 15 PENILE IMPLANT MANUFACTURERS' U.S. MARKET SHARES, 2004 (PERCENT OF TOTAL SALES)
Dental Prostheses
Description
Applications
Technology
Removable Dentures
Crowns and Bridges
Dental Implants
Patents
Table 26 U.S. DENTAL PROSTHESIS PATENTS ISSUED SINCE 1976 ($ MILLIONS, %)
Figure 16 U.S. DENTAL PROSTHESIS PATENTS ISSUED SINCE 1976 (%)
Manufacturers
Table 27 DENTAL PROSTHESIS MANUFACTURERS
Table 28 DENTAL IMPLANT MARKET SHARES, 2004 ($ MILLIONS, %)
Figure 17 DENTAL IMPLANT MARKET SHARES, 2004 (% OF TOTAL SALES)
Bone Implants
Description
Applications
Technologies
Ceramic-Based Bone Substitutes
Polymer-Based Bone Substitutes
Patents
Table 29 U.S. BONE PROSTHESIS PATENTS, ISSUED SINCE 1976 (NUMBER, %)
Figure 18 U.S. BONE PROSTHESIS PATENTS, ISSUED SINCE 1976 (%)
Manufacturers
Table 30 BONE PROSTHESIS MANUFACTURERS
NON-FUNCTIONAL PROSTHESES
EYES
Description
Applications
Technology
Ocular Prosthesis
Orbital Implants
Patents
Table 31 U.S. PATENTS ISSUED SINCE 1976 RELATING TO ARTIFICIAL EYES (NUMBER, %)
Figure 19 U.S. PATENTS ISSUED SINCE 1976 RELATING TO ARTIFICIAL EYES (%)
Manufacturers
Table 32 ARTIFICIAL EYE MANUFACTURERS
BREASTS
Description
Applications
Technologies
Patents
Table 33 HOLDERS OF U.S. BREAST PROSTHESIS PATENTS, ISSUED SINCE 1976 (NUMBER, %)
Figure 20 HOLDERS OF U.S. BREAST PROSTHESIS PATENTS, ISSUED SINCE 1976 (%)
Manufacturers
Table 34 PROSTHETIC BREAST MANUFACTURERS
ORTHOTICS
DESCRIPTION
APPLICATIONS
TECHNOLOGIES
Ankle-Foot Orthoses
Foot Orthoses
Knee Orthoses
Spinal Orthoses
PATENTS
Table 35 U.S. ORTHOTICS PATENTS, ISSUED SINCE 1976, BY BODY PART (NUMBER, %)
Figure 21 U.S. ORTHOTICS PATENTS, ISSUED SINCE 1976, BY BODY PART (%)
Table 36 U.S. ORTHOTICS PATENT HOLDERS, ISSUED SINCE 1976 (%)
MANUFACTURERS
Table 37 ORTHOTICS MANUFACTURERS
Table 38 LEADING SUPPLIERS TO THE U.S. ORTHOTICS MARKET, 2004 ($ MILLIONS, %)
Figure 22 LEADING SUPPLIERS TO THE U.S. ORTHOTICS MARKET, 2004 (PERCENT OF TOTAL SALES)
COSMETIC ENHANCEMENT PRODUCTS
COSMETIC IMPLANTS
Breast Implants
Description
Applications
Technology
Patents
Manufacturers
Facial Implants
Description
Applications
Technology
Solid Silicone
Porous Polyethylene
Gore-tex
Patents
Table 39 U.S. FACIAL IMPLANT PATENTS, ISSUED SINCE 1976 (NUMBER, %)
Figure 23 U.S. FACIAL IMPLANT PATENTS, ISSUED SINCE 1976 (%)
Manufacturers
Table 40 FACIAL IMPLANT MANUFACTURERS
COSMETIC INJECTIONS
Botulinum Toxin Neuromodulators
Description
Applications
Technologies
Patents
Manufacturers
Dermal Fillers
Description
Applications
Technology
Bovine Collagen
Hyaluronic Acid
Hylaform Gel
Restylane
Calcium Hydroxyapatite Microspheres
Polymethylmethacrylate (PMMA) Microspheres
Patents
Manufacturers
Table 41 DERMAL FILLER MANUFACTURERS
U.S. MARKET FOR PROSTHESES, ORTHOTICS AND COSMETIC ENHANCEMENT PRODUCTS
SUMMARY
Table 42 U.S. MARKET FOR PROSTHETICS ORTHOTICS AND COSMETIC ENHANCEMENT PRODUCTS, THROUGH 2010 ($ MILLIONS)
Figure 24 U.S. MARKET FOR PROSTHETICS ORTHOTICS AND COSMETIC ENHANCEMENT PRODUCTS, 2004-2010 ($ MILLIONS)
Table 43 SHARE OF PROSTHETIC, ORTHOTIC AND COSMETIC ENHANCEMENT PRODUCTS, 2004 AND 2010 (%)
Figure 25 SHARE OF PROSTHETIC, ORTHOTIC AND COSMETIC ENHANCEMENT PRODUCTS, 2004 AND 2010 (%)
DETAILED MARKET ESTIMATES AND PROJECTIONS, 2004-2010
PROSTHETICS
Table 44 U.S. SALES OF FUNCTIONAL AND NON-FUNCTIONAL PROSTHESES, THROUGH 2010 ($ MILLIONS)
Functional Prostheses
Table 45 PROJECTED U.S. MARKET FOR FUNCTIONAL PROSTHESES BY TYPE, THROUGH 2010 ($ MILLIONS)
Table 46 SHARE OF U.S. FUNCTIONAL PROSTHESIS MARKET BY TYPE OF DEVICE, 2004 AND 2010 (%)
Figure 26 SHARE OF U.S. FUNCTIONAL PROSTHESIS MARKET BY TYPE OF DEVICE, 2004 AND 2010 (%)
Exoprostheses
Historical Sales
Table 47 SHARE OF U.S. SALES OF EXOPROSTHESES, INCLUDING HIP AND KNEE IMPLANTS (%)
Figure 27 SHARE OF U.S. SALES OF EXOPROSTHESES, INCLUDING HIP AND KNEE IMPANTS (PERCENT OF TOTAL SALES)
Aging of the U.S. Population
Table 48 INCIDENCE OF DIABETES AMONG DIFFERENT AGE GROUPS (%)
Table 49 PROJECTED TRENDS IN U.S. POPULATION 55 YEARS AND OLDER VS. ENTIRE POPULATION (MILLION PERSONS)
Trends in Arthroplasties
Table 50 NUMBER OF U.S. HIP AND KNEE REPLACEMENTS*, THROUGH 2010 (THOUSANDS OF PROCEDURES)
Trends in Diabetes
Projected Market
Table 51 PROJECTED U.S. MARKET FOR EXOPROSTHESES, THROUGH 2010 ($ MILLIONS)
Implanted Prostheses
Prosthetic Hearts/Valves
Historical Sales
Market Drivers
Bridge to Transplant Applications
Table 52 U.S. HEART TRANSPLANT TRENDS, 1999-2004
Figure 28 U.S. HEART TRANSPLANT TRENDS, 1999-2004 (NUMBER)
Destination Therapy Applications
Rate of Technology Adoption
Insurance Coverage
Table 53 SOURCES OF MEDICAL INSURANCE COVERAGE FOR AMERICANS 65 YEARS AND OLDER, 2004 (NUMBER, %)
Figure 29 SOURCES OF MEDICAL INSURANCE COVERAGE FOR AMERICANS 65 YEARS AND OLDER, 2004 (%)
Constraints on Number of Qualified Surgeons
Projected Sales
Table 54 U.S. CARDIAC PROSTHESIS SALES, THROUGH 2010 ($ MILLIONS)
Ocular Prostheses
Historical Sales
Market Drivers
Projected Sales
Auditory Prostheses
Table 55 U.S. SALES OF AUDITORY PROSTHESES BY TYPE, THROUGH 2010 ($ MILLIONS)
Cochlear Implants
Historical Sales
Market Drivers
Table 56 COCHLEAR IMPLANT MARKET PENETRATION, 2004 (NUMBER, %)
Figure 30 COCHLEAR IMPLANT MARKET PENETRATION, 2004 (%)
Projected Sales
Table 57 U.S. SALES OF COCHLEAR IMPLANT, THROUGH 2010 ($ MILLIONS)
Middle Ear Implants
Historical Sales
Market Drivers
Projected Sales
Table 58 U.S. SALES OF MIDDLE EAR IMPLANTS, THROUGH 2010 ($ MILLIONS)
Neural Prostheses
Historical Sales
Market Drivers
Projected Sales
Table 59 U.S. MARKET FOR SPINAL NERVE STIMULATORS USED FOR SPINAL CORD INJURY, THROUGH 2010 ($ MILLIONS)
Urological Prostheses
Table 60 U.S. MARKET FOR UROLOGICAL PROSTHESES, THROUGH 2010 ($ MILLIONS)
Penile Prostheses
Historical Sales
Market Drivers
Projected Sales
Table 61 TRENDS IN U.S. SALES OF PENILE IMPLANTS, THROUGH 2010 ($ MILLIONS)
Urethral Sphincter Prostheses
Historical Sales
Market Drivers
Projected Sales
Table 62 TRENDS IN U.S. SALES OF URINARY PROSTHESES, THROUGH 2010 ($ MILLIONS)
Artificial Bone Grafts
Historical Sales
Table 63 U.S. SALES OF ARTIFICIAL VS NATURAL BONE SUBSTITUTE MATERIALS, 2004 ($ MILLIONS, %)
Figure 31 U.S. SALES OF ARTIFICIAL VS NATURAL BONE SUBSTITUTE MATERIALS, 2004 (PERCENT OF TOTAL SALES)
Market Drivers
Trends in the U.S. Bone Graft Market
Table 64 PROJECTED U.S., MARKET FOR BONE GRAFT MATERIALS, THROUGH 2010 ($ MILLIONS)
Substitution of Artificial for Natural Bone Products
Projected Sales
Table 65 PROJECTED U.S. MARKET FOR ARTIFICIAL BONE GRAFT MATERIALS, THROUGH 2010 ($ MILLIONS)
Dental Prostheses
Historical Sales
Table 66 U.S. DENTAL PROSTHETIC MARKET BY TYPE, 2004 ($ MILLIONS, %)
Figure 32 U.S. DENTAL PROSTHETIC MARKET BY TYPE, 2004 (PERCENT OF TOTAL SALES)
Market Drivers
Aging of the U.S. Population
Declining Use of Removable Dentures
Current Low Market Penetration of Dental Implants
Promotion by Implant Manufacturers
Projected Sales
Table 67 U.S. MARKET FOR DENTAL PROSTHESES BY TYPE, THROUGH 2010 ($ MILLIONS)
NON-FUNCTIONAL PROSTHESES
Table 68 U.S. MARKET FOR NON-FUNCTIONAL PROSTHESES BY TYPE, THROUGH 2010 ($ MILLIONS)
Breast Prostheses
Historical Sales
Table 69 U.S. MARKET FOR EXTERNAL AND IMPLANTED BREAST PROSTHESES, 2004 ($ MILLIONS, %)
Figure 33 U.S. MARKET FOR EXTERNAL AND IMPLANTED BREAST PROSTHESES, 2004 (PERCENT OF TOTAL SALES)
Market Drivers
Trends in the Number of New Diagnoses of Breast Cancer
Table 70 TRENDS IN THE NUMBER OF NEW BREAST CANCER CASES IN THE U.S., THROUGH 2004 (THOUSAND CASES)
Trends in Breast Mastectomies and Lumpectomies vs. Other Forms of Therapy for Breast Cancer
Trends in Use External vs. Implanted Breast Prostheses
Projected Sales
Table 71 U.S. MARKET FOR EXTERNAL AND IMPLANTED BREAST PROSTHESES, THROUGH 2010 ($ MILLIONS)
Artificial Eyes
Historical Sales
Table 72 U.S. MARKET FOR ARTIFICIAL EYES BY TYPE, 2004 ($ MILLIONS, %)
Figure 34 U.S. MARKET FOR ARTIFICIAL EYES BY TYPE, 2004 (PERCENT OF TOTAL SALES)
Market Drivers
Projected Sales
Table 73 U.S. SALES OF ARTIFICIAL EYES, THROUGH 2010 ($ MILLIONS)
ORTHOTICS
Historical Sales
Table 74 U.S. ORTHOTICS MARKET BY TYPE, 2004 ($ MILLIONS, %)
Figure 35 U.S. ORTHOTICS MARKET BY TYPE, 2004 (PERCENT OF TOTAL SALES)
Market Drivers
Aging of the U.S. Population
Table 75 U.S., POPULATION BY AGE GROUP, THROUGH 2010 (MILLION PERSONS)
Table 76 TRENDS IN U.S. POPULATION 55 AND OLDER, 2004 AND 2010 (PERCENT OF TOTAL U.S. POPULATION)
Figure 36 TRENDS IN U.S. POPULATION 55 AND OLDER, 2004 AND 2010 (PERCENT OF TOTAL U.S. POPULATION)
Increasing Sports Participation
Table 77 TRENDS IN U.S., SPORTS PARTICIPATION, 1999 AND 2004 (MILLIONS OF AMERICANS PARTICIPATING IN SPORTS AT LEAST ONCE)
Figure 37 TRENDS IN U.S., SPORTS PARTICIPATION, 1999 AND 2004 (MILLIONS OF AMERICANS PARTICIPATING IN SPORTS AT LEAST ONCE)
Technological Advances
Projected Sales
Table 78 U.S. SALES OF ORTHOTIC DEVICES, THROUGH 2010 ($ MILLIONS)
COSMETIC ENHANCEMENT PRODUCTS
Table 79 U.S. SALES OF COSMETIC ENHANCEMENT PRODUCTS BY TYPE, THROUGH 2004 ($ MILLIONS)
Breast Implants
Historical Sales
Market Drivers
Trends in Number of Cosmetic Breast Implant Procedures
Table 80 TRENDS IN U.S. COSMETIC BREAST IMPLANT PROCEDURES, 1999-2004
Availability of Silicone Implants
Projected Sales
Table 81 U.S. SALES OF COSMETIC BREAST IMPLANTS, THROUGH 2010 ($ MILLIONS)
Facial Implants
Historical Demand
Market Drivers
Table 82 MAJOR FACIAL COSMETIC PROCEDURES, THROUGH 2004
Projected Sales
Table 83 U.S. SALES OF FACIAL IMPLANTS, THROUGH 2010 ($ MILLIONS)
Botulinum Toxin Injections
Historical Sales
Market Drivers
Projected Sales
Table 84 U.S. MARKET FOR BOTULINUM INJECTIONS, THROUGH 2010 ($ MILLIONS)
Dermal Fillers
Historical Sales
Table 85 U.S. DERMAL FILLER SALES BY TYPE, 2004 ($ MILLIONS, %)
Figure 38 U.S. DERMAL FILLER SALES BY TYPE, 2004 (PERCENT OF TOTAL SALES)
Market Drivers
Projected Sales
Table 87 U.S. MARKET FOR DERMAL IMPLANTS*, THROUGH 2010 ($ MILLIONS)
VENDOR PROFILES
ABIOMED, INC.
Table 88 ABIOMED FINANCIAL PERFORMANCE 2001-2004 ($ MILLIONS)
ADVANCED BIONICS CORP.
ALLERGAN, INC.
ALLHEAR, INC.
AMERICAN MEDICAL SYSTEMS
AMERICAN BREAST CARE
AMOENA
ANGSTROM MEDICA. INC.
ARROW INTERNATIONAL
BIOMET, INC.
BLEDSOE BRACE SYSTEMS
BRAINLAB AG
B. BRAUN AESCULAP
CLEVELAND FES CENTER
COCHLEAR LIMITED
THE DOBELLE INSTITUTE
THE FILLAUER COMPANIES
FINETECH MEDICAL, LTD.
IMPLANT INNOVATIONS INC.
INTEGRATED SURGICAL SYSTEMS, INC.
LIBERATING TECHNOLOGIES, INC.
MED-EL
MEDTRONIC INC.
MENTOR CORP.
MICROMED TECHNOLOGY INC.
NEOPRAXIS PTY. LTD.
NEUROCONTROL INC.
NOBEL BIOCARE
ORTHOVITA INC.
Table 89 ORTHOVITA INC. FINANCIAL PERFORMANCE 1998-2002 ($ MILLIONS)
OSSUR
OTOLOGICS, LLC
OTTO BOCK HEALTHCARE GMBH
POREX CORPORATION
SEATTLE SYSTEMS INC.
SOUNDTEC, INC.
STRAUMANN HOLDING AG
STRYKER CORP.
SYMPHONIX DEVICES
THORATEC CORP.
Table 90 THORATEC CORP. FINANCIAL PERFORMANCE, 2001-2004 ($ MILLIONS)
VICTHOM HUMAN BIONICS
WORLDHEART CORP.
Table 91 WORLDHEART CORP. FINANCIAL PERFORMANCE, 2001-2004 ($ MILLIONS)
ZIMMER INC. |
Order Form * Please reference product number R2-1113 when ordering or inquiring.
MindBranch, Inc.,
131 Ashland St., Suite 200 North Adams, MA 01247
tel: 800-774-4410
fax: +1-413-664-9791
www.mindbranch.com
|
